Brief Article
Copyright ©2009 The WJG Press and Baishideng.
World J Gastroenterol. Dec 21, 2009; 15(47): 5966-5971
Published online Dec 21, 2009. doi: 10.3748/wjg.15.5966
Table 1 Univariate analysis of the predictors for survival of the 45 patients who underwent radical BDSR for PBD-1 or MBD disease
CharacteristicNumber of patientsMedian survival time (mo)Survival rate (%)
P-value
3-yr5-yr
Overall452551.736.6
Age (yr)0.466
≤ 65254256.438.7
> 65203345.534.1
Gender0.314
Male30354728.2
Female154258.248.5
CA19-9 (U/mL)0.519
≤ 35194251.625.8
> 35195561.549.2
No data7
Bilirubin at admission (mg/dL)0.368
≤ 1.611NR53.353.3
> 1.6344250.534.1
Bilirubin at operation (mg/dL)0.149
≤ 1.6175565.543.6
> 1.6282943.731.9
Preoperative biliary drainage0.632
No1035400.0
Yes354253.842.3
Location0.547
MBD344251.444.1
PBD-1115251.926
LN dissection0.997
D184258.329.2
D2375251.242.6
Transfusion0.832
No364251.239.4
Yes93347.623.8
Size (cm)0.892
≤ 2.026354739.2
> 2.0195256.633.9
T stage< 0.001
T19NR100100
T2333549.631.5
T33160.00.0
LN stage0.010
N0325263.142.6
N1132519.219.2
TNM stage0.012
 Ia9NR100100
 Ib234255.832.6
IIb132519.219.2
Cell differentiation0.005
Well15NR87.557.5
Moderate263341.633.3
Poor4220.00.0
Perineural invasion0.180
No13NR71.171.1
Yes323547.729.8
Table 2 The clinical characteristics of the BDSR group were compared with the PD group n (%)
CharacteristicsBDSR groupPD group
Total patients45149
Age (median, yr)65 (37-76)60 (31-78)
Gender
Male30 (66.7)102 (68.5)
Female15 (33.3)47 (31.5)
Median follow-up (mo)25.0 (4.0-104.0)21.9 (0.4-108.5)
T stage
T19 (20.0)32 (21.4)
T233 (73.3)20 (13.4)
T33 (6.7)90 (60.5)
T40 (0.0)7 (4.7)
N status
N032 (71.2)101 (67.8)
N113 (28.8)48 (32.2)
TNM stage
 Ia9 (20.0)24 (16.1)
 Ib23 (51.1)15 (10.1)
IIa0 (0.0)58 (38.9)
IIb13 (28.9)44 (29.5)
III0 (0.0)8 (5.4)